DK0743522T3 - Stabiliseret troponinsammensætning til immunoassays og fremgangsmåde til fremstilling heraf - Google Patents

Stabiliseret troponinsammensætning til immunoassays og fremgangsmåde til fremstilling heraf

Info

Publication number
DK0743522T3
DK0743522T3 DK96401041T DK96401041T DK0743522T3 DK 0743522 T3 DK0743522 T3 DK 0743522T3 DK 96401041 T DK96401041 T DK 96401041T DK 96401041 T DK96401041 T DK 96401041T DK 0743522 T3 DK0743522 T3 DK 0743522T3
Authority
DK
Denmark
Prior art keywords
immunoassays
preparation
methods
composition
stabilized troponin
Prior art date
Application number
DK96401041T
Other languages
English (en)
Inventor
Denis Robert Marie Riochet
Original Assignee
Pasteur Sanofi Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Sanofi Diagnostics filed Critical Pasteur Sanofi Diagnostics
Application granted granted Critical
Publication of DK0743522T3 publication Critical patent/DK0743522T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
DK96401041T 1995-05-16 1996-05-13 Stabiliseret troponinsammensætning til immunoassays og fremgangsmåde til fremstilling heraf DK0743522T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9505788A FR2734267B1 (fr) 1995-05-16 1995-05-16 Composition stabilisee de troponine pour immunoessais et procede de preparation d'une telle composition stabilisee

Publications (1)

Publication Number Publication Date
DK0743522T3 true DK0743522T3 (da) 1999-05-10

Family

ID=9479025

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96401041T DK0743522T3 (da) 1995-05-16 1996-05-13 Stabiliseret troponinsammensætning til immunoassays og fremgangsmåde til fremstilling heraf

Country Status (9)

Country Link
US (2) US20010006683A1 (da)
EP (1) EP0743522B1 (da)
JP (1) JP3672672B2 (da)
AT (1) ATE169740T1 (da)
CA (1) CA2176655C (da)
DE (1) DE69600512T2 (da)
DK (1) DK0743522T3 (da)
ES (1) ES2122768T3 (da)
FR (1) FR2734267B1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7285418B2 (en) 1996-06-25 2007-10-23 Hytest Ltd. Method and kit for the diagnosis of troponin I
DE69724636T2 (de) * 1996-06-25 2004-09-16 Hytset Ltd. Verfahren und kit zur diagnose von troponin i
DE19647927A1 (de) * 1996-11-20 1998-05-28 Bayer Ag Verfahren zur Herstellung einer stabilen Troponin I Präparation und dessen Verwendung als Kalibrator in Immunoassays
US5834210A (en) * 1997-05-23 1998-11-10 Spectral Diagnostics, Inc. Stable troponin subunits and complexes
US6248869B1 (en) 1997-05-29 2001-06-19 Medical Analysis Systems, Inc. Troponin I forms and use of the same
JP2002508839A (ja) * 1997-05-29 2002-03-19 メディカル アナリシス システムズ，インコーポレイテッド 共有結合したトロポニン複合体
EP1000140A1 (en) * 1997-06-13 2000-05-17 Medical Analysis Systems, Inc. (MAS) Stabilized compositions of cardiac markers
WO2006116005A2 (en) * 2005-04-28 2006-11-02 Abbott Laboratories Stabilization of cardiac troponin
WO2012115221A1 (ja) * 2011-02-25 2012-08-30 三菱化学メディエンス株式会社 心筋トロポニンの測定法
JP5759211B2 (ja) * 2011-03-11 2015-08-05 三洋化成工業株式会社 凍結乾燥方法
CN113125745B (zh) * 2019-12-31 2022-10-28 瑞博奥(广州)生物科技股份有限公司 一种心脏功能检测试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2027434C (en) * 1990-10-12 1999-01-05 George Jackowski Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
DE4243648A1 (de) * 1992-12-23 1994-07-07 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Herzmuskelnekrosen mittels Antikörper gegen das N-terminale Troponin I-Peptid
FR2701954B1 (fr) * 1993-02-23 1995-07-07 Pasteur Sanofi Diagnostics Composition stabilisée de troponine pour immunoessais et procédé de stabilisation de troponine pour immunoessais.
AU689777B2 (en) * 1993-05-17 1998-04-09 Fortron Bioscience, Inc. Assay for cardiac troponin I
DE4420742A1 (de) * 1993-10-20 1995-04-27 Boehringer Mannheim Gmbh Synthetischer Standard für Immunoassays

Also Published As

Publication number Publication date
EP0743522B1 (fr) 1998-08-12
US20040033529A1 (en) 2004-02-19
CA2176655A1 (en) 1996-11-17
DE69600512T2 (de) 1999-04-15
FR2734267A1 (fr) 1996-11-22
US20010006683A1 (en) 2001-07-05
ATE169740T1 (de) 1998-08-15
EP0743522A1 (fr) 1996-11-20
JP3672672B2 (ja) 2005-07-20
CA2176655C (en) 2002-01-29
FR2734267B1 (fr) 1997-08-01
JPH0921804A (ja) 1997-01-21
ES2122768T3 (es) 1998-12-16
DE69600512D1 (de) 1998-09-17

Similar Documents

Publication Publication Date Title
DE3675440D1 (de) Neue pfropfpolymerisate und deren abmischungen mit polyamiden.
NO853696L (no) Diarylacetylener, fremstilling og anvendelse derav.
DK0743522T3 (da) Stabiliseret troponinsammensætning til immunoassays og fremgangsmåde til fremstilling heraf
IT8122675A0 (it) Mercaptoacil derivati di varie proline 4 sostituite e relative composizioni utili per il trattamento dell'ipertensione.
DE68911195D1 (de) Wenig klebende Zusammensetzungen von Perfluoropolyether.
DE68912821D1 (de) Regelung der Dichtungsstärkeverminderung mit spannungsabhängiger Rückkopplung.
DK0642530T3 (da) Dolastatinderivater
FI853624L (fi) 1-substituerade tetralinderivat, deras framstaellning och anvaendning.
NO871053D0 (no) Anvendelse av substituerte n-triklormetyltiodikarboksimider i kombinasjon med n,n[-substituerte bis-(2,4-diamino-s-triazin-6-yl)-oligosulfider i vulkaniserbare kautsjukblandinger og slike kautsjukblandinger.
DK0401896T3 (da) Carboplatinmateriale
GR75124B (da)
DE3885501D1 (de) Butadien-Styrol-Blockcopolymere mit unsymmetrischem Aufbau und deren Herstellung und Verwendung als Formmassen.
DK0581982T3 (da) Svingdør til kundeføringsanlæg
DE3581185D1 (de) Neue pfropfpolymerisate und deren abmischungen mit polyamiden.
IT1188231B (it) Metodo di controllo dell'iniezione di combustibile
IT206626Z2 (it) Termostato dotato di morsetti d'uscita allineati.
DE3787429D1 (de) Minimierung von Anschlussinseln des Typs "Engineering Change".
DK158738C (da) 5-(omega-phenethylamino-alkyl)-4,5,6,7-tetrahydro-thieno-(3,2-c)-pyridinderivater og laegemiddel indeholdende saadanne forbindelser
DE3683158D1 (de) Faerbende zusammensetzung.
FI821141L (fi) 5,6-dihydro-11-alkylen-morfantridin-6-one, deras framstaellning och dessa innehaollande laekemedel
FR2578626B1 (fr) Gazogene fonctionnant au bois d'hevea
ITPN910032U1 (it) Sigillo di garanzia
ES2053474T3 (es) 1,2,3-tiadazol-4-tiolatos substituidos.
IT1183542B (it) Struttura di valvola con azionamento controllato dell'otturatore